EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOMYG00000001038
Gene Symbol: IDH2
1 Cross references
201 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSOMYG00000011445
Gene Symbol: KEAP1B
2 Cross references
188 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSOMYG00000058246
Gene Symbol: KEAP1B
2 Cross references
188 Possible Orthologues:

Kinase Insert Domain Receptor (A Type Iii Receptor Tyrosine Kinase)

Ensembl ID : ENSOMYG00000005763
Gene Symbol: KDR
2 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSOMYG00000041944
Gene Symbol: KIF11
1 Cross references
196 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSOMYG00000045084
Gene Symbol: KIF11
1 Cross references
196 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOMYG00000045807
Gene Symbol: KIF5B
1 Cross references
262 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOMYG00000027759
Gene Symbol: KIF5B
1 Cross references
262 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSOMYG00000044369
Gene Symbol: LTB4R2B
1 Cross references
161 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSOMYG00000022683
Gene Symbol: LTB4R2B
1 Cross references
161 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSOMYG00000020905
Gene Symbol: KDM1A
1 Cross references
207 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSOMYG00000007963
Gene Symbol: KDM1A
2 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).